Rapilif 8mg 15 Capsules

babies: not applicable. lactating mothers: not applicable. pregnancy: not applicable. alcohol: avoid consumption of alcohol while taking this medicine as it causes excessive drowsiness. driving: this medicine may cause dizziness, weakness and alters your ability to drive. do not drive if you experience these symptoms.
kidney: this medicine should be used with caution in patients with kidney disease. dose adjustment is required.
seek a doctor's advice before taking this medicine. it is not recommended in patients with severe kidney disease. liver: this medicine should be used with caution in patients with severe liver diseases.
studies have shown that dose adjustment is required in these patients. seek a doctor's advice before using this medicine..

dizziness diarrhea headache orthostatic hypertension nasal congestion retrograde ejaculation.

rapilif belongs to the class of alpha-1 adrenergic blocker used in the treatment of benign prostatic hyperplasia. it works by relaxing the muscles in the bladder and prostate gland to relieve the symptoms of difficulty in urination..

if you miss a dose, take it as soon as possible. if it is near the time of the next dose, then skip the missed dose.
take the prescribed dose on your regular time daily. don't double the dose to catch up with the missed dose..

• take this medicine as prescribed by your doctor. • to get better results to take this medicine at a fixed time regularly. • finish the full course of this medicine. • do not stop taking this medicine too early without consulting your doctor. • if you experience dizziness, nasal congestion, nasopharyngitis, headache, and blurred vision for a longer duration while taking this medicine, inform your doctor..

major • rapilif + atazanavir: concurrent use may lead to an increase in the risk of heart rate • rapilif + clarithromycin: concurrent use may lead to a decrease in the blood pressure • rapilif + indinavir: concurrent use may lead to an increase in the risk of heart rate • rapilif + itraconazole: concurrent use may lead to a decrease in the blood pressure • rapilif + voriconazole: concurrent use may lead to an increase in the risk of heart rate moderate • rapilif + acebutolol: concurrent use may lead to an increase in the risk of irregular heartbeat and headache • rapilif + alprazolam: concurrent use may lead to an increase in the risk of headache and heart rate • rapilif + cimetidine: concurrent use may lead to an increase in the risk of heart rate • rapilif + diazepam: concurrent use may lead to an increase in the risk of headache and heart rate • rapilif + fluconazole: concurrent use may lead to an increase in the risk of heart rate.